Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis

Intravenous immunoglobulin (IVIG) has been utilized in patients with recurrent and refractory Clostridium difficile colitis. It is increasingly being used in patients with initial clinical presentation of severe colitis. Herein, we report a case of severe C. Difficile colitis successfully treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Nihar, Shaaban, Hamid, Spira, Robert, Slim, Jihad, Boghossian, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049046/
https://www.ncbi.nlm.nih.gov/pubmed/24926170
http://dx.doi.org/10.4103/0974-777X.132053
_version_ 1782480586652254208
author Shah, Nihar
Shaaban, Hamid
Spira, Robert
Slim, Jihad
Boghossian, Jack
author_facet Shah, Nihar
Shaaban, Hamid
Spira, Robert
Slim, Jihad
Boghossian, Jack
author_sort Shah, Nihar
collection PubMed
description Intravenous immunoglobulin (IVIG) has been utilized in patients with recurrent and refractory Clostridium difficile colitis. It is increasingly being used in patients with initial clinical presentation of severe colitis. Herein, we report a case of severe C. Difficile colitis successfully treated with IVIG with a review of the medical literature to identify the optimal timing and clinical characteristics for this treatment strategy.
format Online
Article
Text
id pubmed-4049046
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-40490462014-06-12 Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis Shah, Nihar Shaaban, Hamid Spira, Robert Slim, Jihad Boghossian, Jack J Glob Infect Dis Case Report Intravenous immunoglobulin (IVIG) has been utilized in patients with recurrent and refractory Clostridium difficile colitis. It is increasingly being used in patients with initial clinical presentation of severe colitis. Herein, we report a case of severe C. Difficile colitis successfully treated with IVIG with a review of the medical literature to identify the optimal timing and clinical characteristics for this treatment strategy. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4049046/ /pubmed/24926170 http://dx.doi.org/10.4103/0974-777X.132053 Text en Copyright: © Journal of Global Infectious Diseases http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Shah, Nihar
Shaaban, Hamid
Spira, Robert
Slim, Jihad
Boghossian, Jack
Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
title Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
title_full Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
title_fullStr Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
title_full_unstemmed Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
title_short Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
title_sort intravenous immunoglobulin in the treatment of severe clostridium difficile colitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049046/
https://www.ncbi.nlm.nih.gov/pubmed/24926170
http://dx.doi.org/10.4103/0974-777X.132053
work_keys_str_mv AT shahnihar intravenousimmunoglobulininthetreatmentofsevereclostridiumdifficilecolitis
AT shaabanhamid intravenousimmunoglobulininthetreatmentofsevereclostridiumdifficilecolitis
AT spirarobert intravenousimmunoglobulininthetreatmentofsevereclostridiumdifficilecolitis
AT slimjihad intravenousimmunoglobulininthetreatmentofsevereclostridiumdifficilecolitis
AT boghossianjack intravenousimmunoglobulininthetreatmentofsevereclostridiumdifficilecolitis

Ejemplares similares